Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review

Date: June 13, 2017
Pages: 46
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A913AB09098EN
Leaflet:

Download PDF Leaflet

Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review
Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Agenus Inc (Agenus) is a clinical-stage immuno-oncology company. It focuses on the development and commercialization of immunotherapeutics for the treatment of diseases in the fields of cancer and infectious diseases. Its business activities include product research and development, regulatory and clinical affairs, manufacturing, corporate finance and development, business development, marketing, intellectual property prosecution and administrative functions. The company's key technology portfolio includes Checkpoint Antibody Program, Saponin Platform and Heat Shock Protein (HSP) Platform. Its major products in the pipeline include candidates for the treatment of genital herpes, glioma, and multiple cancer types and infectious diseases such as malaria and shingles. The company has partnerships with several pharmaceutical companies such as GSK, Incyte, and universities such as UC San Francisco and UW Seattle. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Agenus Inc Key Recent Developments

May 04,2017: Agenus Reports First Quarter 2017 Financial Results and Provides Corporate Update
Mar 30,2017: Agenus Restructures Business to Sharpen Focus on Clinical Development of Cancer Therapies
Mar 24,2017: Agenus to Participate at Two Upcoming Immuno-Oncology Conferences
Mar 09,2017: Agenus Reports Fourth Quarter and Full Year 2016 Results
Jan 30,2017: Agenus Appoints Jean-Marie Cuillerot, M.D. Chief Medical Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Agenus Inc - Key Facts
Agenus Inc - Key Employees
Agenus Inc - Key Employee Biographies
Agenus Inc - Major Products and Services
Agenus Inc - History
Agenus Inc - Company Statement
Agenus Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Agenus Inc - Business Description
Agenus Inc - SWOT Analysis
SWOT Analysis - Overview
Agenus Inc - Strengths
Agenus Inc - Weaknesses
Agenus Inc - Opportunities
Agenus Inc - Threats
Agenus Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Agenus Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 04, 2017: Agenus Reports First Quarter 2017 Financial Results and Provides Corporate Update
Mar 30, 2017: Agenus Restructures Business to Sharpen Focus on Clinical Development of Cancer Therapies
Mar 24, 2017: Agenus to Participate at Two Upcoming Immuno-Oncology Conferences
Mar 09, 2017: Agenus Reports Fourth Quarter and Full Year 2016 Results
Jan 30, 2017: Agenus Appoints Jean-Marie Cuillerot, M.D. Chief Medical Officer
Oct 27, 2016: Agenus Reports Third Quarter Financial Results and Recent Highlights
Oct 18, 2016: Agenus Appoints James Gorman, M.D., Ph.D. as Vice President of Strategic Planning and Portfolio Management
Jul 28, 2016: Agenus Reports Second Quarter 2016 Financial Results and Operational Progress
Jul 06, 2016: Agenus Appoints Jean-Marie Cuillerot, M.D. as Vice President and Global Head of Clinical Development
May 19, 2016: Agenus Appoints Ulf Wiinberg to Board of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Agenus Inc, Key Facts
Agenus Inc, Key Employees
Agenus Inc, Key Employee Biographies
Agenus Inc, Major Products and Services
Agenus Inc, History
Agenus Inc, Subsidiaries
Agenus Inc, Key Competitors
Agenus Inc, Ratios based on current share price
Agenus Inc, Annual Ratios
Agenus Inc, Annual Ratios (Cont.1)
Agenus Inc, Interim Ratios
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Agenus Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Agenus Inc, Performance Chart (2012 - 2016)
Agenus Inc, Ratio Charts
Agenus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Agenus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

TVAX Biomedical Inc
Oxford BioMedica Plc
Northwest Biotherapeutics Inc
Juvaris BioTherapeutics Inc
ImmunoCellular Therapeutics Ltd
Idera Pharmaceuticals Inc
Green Cross Cell Corp
Dynavax Technologies Corp
Celldex Therapeutics Inc
Skip to top


Ask Your Question

Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: